BRUGADA SYNDROME (BRS)
Clinical trials for BRUGADA SYNDROME (BRS) explained in plain language.
Never miss a new study
Get alerted when new BRUGADA SYNDROME (BRS) trials appear
Sign up with your email to follow new studies for BRUGADA SYNDROME (BRS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Diabetes drug shows promise for rare heart condition in new trial
Disease control Not yet recruitingThis early-stage trial tests whether empagliflozin, a diabetes drug, can improve abnormal heart electrical patterns in people with Brugada syndrome. Ten adults will take the medicine daily for three months, with monthly checkups to monitor heart changes and side effects. The goal…
Matched conditions: BRUGADA SYNDROME (BRS)
Phase: PHASE2 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated May 26, 2026 05:22 UTC
-
Could cancer antibodies harm the heart? new study investigates
Knowledge-focused Not yet recruitingThis study aims to find out if people with metastatic breast or colon cancer produce antibodies that might also attack the heart, potentially causing dangerous heart rhythms. Researchers will test blood samples from 196 participants at the start of the study and again after 6 and…
Matched conditions: BRUGADA SYNDROME (BRS)
Phase: NA • Sponsor: IRCCS Policlinico S. Donato • Aim: Knowledge-focused
Last updated May 22, 2026 14:05 UTC